Literature DB >> 14623073

The PIR domain of Grb14 is an intrinsically unstructured protein: implication in insulin signaling.

Karine Moncoq1, Isabelle Broutin, Valéry Larue, Dominique Perdereau, Katia Cailliau, Edith Browaeys-Poly, Anne-Françoise Burnol, Arnaud Ducruix.   

Abstract

Grb14 belongs to the Grb7 family of adapter proteins and was identified as a negative regulator of insulin signal transduction. Its inhibitory effect on the insulin receptor kinase activity is controlled by a newly discovered domain called PIR. To investigate the biochemical and biophysical characteristics of this new domain, we cloned and purified recombinant PIR-SH2, PIR, and SH2 domains. The isolated PIR and PIR-SH2 domains were physiologically active and inhibited insulin-induced reinitiation of meiosis in the Xenopus oocytes system. However, NMR experiments on (15)N-labelled PIR revealed that it did not present secondary structure. These results suggest that the PIR domain belongs to the growing family of intrinsically unstructured proteins.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14623073     DOI: 10.1016/s0014-5793(03)01095-0

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  12 in total

1.  SAXS study of the PIR domain from the Grb14 molecular adaptor: a natively unfolded protein with a transient structure primer?

Authors:  K Moncoq; I Broutin; C T Craescu; P Vachette; A Ducruix; D Durand
Journal:  Biophys J       Date:  2004-10-01       Impact factor: 4.033

2.  Structural basis for inhibition of the insulin receptor by the adaptor protein Grb14.

Authors:  Rafael S Depetris; Junjie Hu; Ilana Gimpelevich; Lowenna J Holt; Roger J Daly; Stevan R Hubbard
Journal:  Mol Cell       Date:  2005-10-28       Impact factor: 17.970

3.  Molecular determinants of Grb14-mediated inhibition of insulin signaling.

Authors:  Diana Goenaga; Cornelia Hampe; Nadège Carré; Katia Cailliau; Edith Browaeys-Poly; Dominique Perdereau; Lowenna J Holt; Roger J Daly; Jean Girard; Isabelle Broutin; Tarik Issad; Anne-Françoise Burnol
Journal:  Mol Endocrinol       Date:  2009-04-09

4.  The TFE-induced transient native-like structure of the intrinsically disordered σ₄⁷⁰ domain of Escherichia coli RNA polymerase.

Authors:  Piotr Kaczka; Maria Winiewska; Igor Zhukov; Bożenna Rempoła; Krystyna Bolewska; Tomasz Łoziński; Andrzej Ejchart; Anna Poznańska; Kazimierz L Wierzchowski; Jarosław Poznański
Journal:  Eur Biophys J       Date:  2014-09-27       Impact factor: 1.733

Review 5.  Grb10 and Grb14: enigmatic regulators of insulin action--and more?

Authors:  Lowenna J Holt; Kenneth Siddle
Journal:  Biochem J       Date:  2005-06-01       Impact factor: 3.857

Review 6.  Regulation of Janus kinases by SOCS proteins.

Authors:  Nadia J Kershaw; James M Murphy; Isabelle S Lucet; Nicos A Nicola; Jeffrey J Babon
Journal:  Biochem Soc Trans       Date:  2013-08       Impact factor: 5.407

7.  A Method for Systematic Assessment of Intrinsically Disordered Protein Regions by NMR.

Authors:  Natsuko Goda; Kana Shimizu; Yohta Kuwahara; Takeshi Tenno; Tamotsu Noguchi; Takahisa Ikegami; Motonori Ota; Hidekazu Hiroaki
Journal:  Int J Mol Sci       Date:  2015-07-10       Impact factor: 5.923

Review 8.  Transient Secondary Structures as General Target-Binding Motifs in Intrinsically Disordered Proteins.

Authors:  Do-Hyoung Kim; Kyou-Hoon Han
Journal:  Int J Mol Sci       Date:  2018-11-15       Impact factor: 5.923

9.  The Anti-Inflammatory Protein TNIP1 Is Intrinsically Disordered with Structural Flexibility Contributed by Its AHD1-UBAN Domain.

Authors:  Rambon Shamilov; Olga Vinogradova; Brian J Aneskievich
Journal:  Biomolecules       Date:  2020-11-10

10.  SOCS3 binds specific receptor-JAK complexes to control cytokine signaling by direct kinase inhibition.

Authors:  Nadia J Kershaw; James M Murphy; Nicholas P D Liau; Leila N Varghese; Artem Laktyushin; Eden L Whitlock; Isabelle S Lucet; Nicos A Nicola; Jeffrey J Babon
Journal:  Nat Struct Mol Biol       Date:  2013-03-03       Impact factor: 15.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.